Publications by authors named "Ken Yoshihara"

Claim this Profile
A
A-910823, a squalene-based emulsion adjuvant, enhances robust and broad immune responses of quadrivalent influenza vaccine in ferrets.
Masayuki Hashimoto, Kenichiro Tsujii, Hitomi Nakajima-Yoshida, Nobuteru Akiyama, Ken Yoshihara

Vaccine· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skin disorder within 30 days is a favorable prognostic factor in patients with lung squamous cell carcinoma treated with necitumumab plus gemcitabine and cisplatin: a sub-analysis of the NINJA study.
Fumihiko Kinoshita, Shigeru Tanzawa, Toshihiro Misumi, Hiroshige Yoshioka, Eisaku Miyauchi, Ken Yoshihara

Ther Adv Med Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical impact of hypomagnesemia induced by necitumumab plus cisplatin and gemcitabine treatment in patients with advanced lung squamous cell carcinoma: a subanalysis of the NINJA study.
Shigeru Tanzawa, Hiroshige Yoshioka, Toshihiro Misumi, Eisaku Miyauchi, Kiichiro Ninomiya, Ken Yoshihara

Ther Adv Med Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokine Release Syndrome More than Two Years after Pembrolizumab Introduction.
Kazuhisa Nakashima, Kashu Kitani, Kento Kono, Ken Yoshihara, Keita Kawakado

Intern Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA Study.
Yasunori Murata, Shigeru Tanzawa, Toshihiro Misumi, Hiroshige Yoshioka, Eisaku Miyauchi, Ken Yoshihara

JTO Clin Res Rep· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognosis of frail older patients treated with intubation and artificial ventilation for respiratory failure.
Kazuhisa Nakashima, Ken Yoshihara, Kento Kono, Mika Horie, Seiko Tanaka

J Med Invest· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-related adverse events in hepatitis treated with thiopurine-based immunosuppressants: A case report.
Keita Kawakado, Kazuhisa Nakashima, Hiroshi Tobita, Mamiko Nagase, Ken Yoshihara

Thorac Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Retrospective Study of Pneumococcal Pneumonia in Hospitalized Patients Aged ≥65 Years in Izumo, Japan: 2010 to 2014.
Megumi Hamaguchi, Yukari Tsubata, Ken Yoshihara, Mika Nakao, Yoshihiro Amano

Int J Gen Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homologous and heterologous booster vaccinations of S-268019-b, a recombinant S protein-based vaccine with a squalene-based adjuvant, enhance neutralization breadth against SARS-CoV-2 Omicron subvariants in cynomolgus macaques.
Masayuki Hashimoto, Shinpei Aoe, Yusuke Kawazu, Naomi M Seki, Kumi Hashimoto, Ken Yoshihara

Vaccine· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys.
Masayuki Hashimoto, Noriyo Nagata, Tomoyuki Homma, Hiroki Maeda, Keiji Dohi, Ken Yoshihara

Vaccine· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of high-dose intravenous immunoglobulin therapy for peripheral neuropathy in the remission stage of eosinophilic granulomatosis with polyangiitis (EGPA, Churg-Strauss syndrome).
Tomoko Matsuda, Yoshihiro Arimura, Ken Yoshihara, Yoshinori Komagata, Shinya Kaname

Nihon Rinsho Meneki Gakkai Kaishi· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AP-VAS 2012 case report: MPO-ANCA-negative relapse of MPO-ANCA-associated vasculitis.
Yoshinori Komagata, Kazufumi Nomura, Ken Yoshihara, Soko Kawashima, Shinya Kaname

CEN Case Rep· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of myeloperoxidase and myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCAs) in the pathogenesis of human MPO-ANCA-associated glomerulonephritis.
Yoshihiro Arimura, Soko Kawashima, Ken Yoshihara, Yoshinori Komagata, Shinya Kaname

Clin Exp Nephrol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Case of MPO-ANCA-associated vasculitis with membranous nephropathy].
Sayaka Watanabe, Yoshihiro Arimura, Kazufumi Nomura, Soko Kawashima, Ken Yoshihara

Nihon Jinzo Gakkai Shi· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[II. Autoimmune disease: 4. ANCA associated gulomerulonephritis/nephritis].
Yoshihiro Arimura, Soko Kawashima, Ken Yoshihara

Nihon Naika Gakkai Zasshi· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphorylation state regulates the localization of Scribble at adherens junctions and its association with E-cadherin-catenin complexes.
Ken Yoshihara, Junichi Ikenouchi, Yasushi Izumi, Masaya Akashi, Shoichiro Tsukita

Exp Cell Res· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac swinging calcified amorphous tumors in end-stage renal failure patients.
Hiroshi Kubota, Yasunori Fujioka, Hideaki Yoshino, Hitoshi Koji, Ken Yoshihara

Ann Thorac Surg· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classification of clinical subtypes, patient survival, kidney prognosis, and relapse in patients with MPO-ANCA-associated vasculitis: a single-center experience.
Kimimasa Nakabayashi, Yoshihiro Arimura, Ken Yoshihara, Toshihiro Fukuoka, Miho Karube

Mod Rheumatol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[ANCA associated vasculitis and PRGN].
Yoshihiro Arimura, Souko Kawashima, Ken Yoshihara

Nihon Jinzo Gakkai Shi· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipoprotein glomerulopathy-like disease in a patient with type III hyperlipoproteinemia due to apolipoprotein E2 (Arg158 Cys)/3 heterozygosity.
Miho Karube, Kimimasa Nakabayashi, Yasunori Fujioka, Ken Yoshihara, Akira Yamada

Clin Exp Nephrol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preservation of hematopoietic properties in transplanted bone marrow cells in the brain.
Kenji Ono, Ken Yoshihara, Hiromi Suzuki, Kenji F Tanaka, Takemasa Takii

J Neurosci Res· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A case of Behçet's disease associated with neuromyopathy induced by combination therapy with colchicine and cyclosporin].
Yuko Fujii, Yoshihiro Arimura, Naoko Takahashi, Takeshi Toki, Tomofumi Marumo, Ken Yoshihara

Ryumachi· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis